Viewing nowCombinationGluriad Tablet 500/2.5 mg
Metformin Hydrochloride 500mg · Glibenclamide 2.5mg
Tablet · Prescription medication · Combination
(Ltd) Daewoong Pharmaceutical

MFDS item code 200307866 · Approved 2003.05.14 · Insurance code 641600190
Treatment of type 2 diabetes mellitus in adults
This medication is used in the treatment of insulin-independent (Type 2) diabetes mellitus in adults. It is administered as a second-line treatment when dietary and exercise therapy alone are insufficient for blood sugar control, or when previous treatments with metformin or sulfonylurea monotherapy have not been effective. It is also utilized to replace prior combined therapy with metformin and sulfonylurea in patients with stable blood sugar control. This medication helps manage diabetes by improving blood sugar regulation.
The usual starting dose is one tablet of metformin hydrochloride/glyburide 500/2.5mg once daily. For patients receiving concomitant metformin hydrochloride and glyburide, administer 2 tablets once daily with a meal. Increase the dose by 1 tablet at intervals of 1 - 2 weeks according to the patient's blood glucose level. The maximum dose is 4 tablets per day of metformin hydrochloride/glyburide 500/5mg.
This medication can cause severe lactic acidosis and hypoglycemia; if such symptoms occur, immediate medical attention is required. Patients with cardiovascular disease should be particularly cautious, as this medication may increase the risk of cardiovascular problems. Patients with severely impaired kidney function, heart failure, or those who have had a recent myocardial infarction should not use this medication. Patients scheduled for examinations using radiological iodinated contrast media should discontinue this medication 48 hours prior to the examination and only resume after normal kidney function is confirmed. This medication should not be administered to individuals with an allergic reaction to it, Type 1 diabetes, diabetic ketoacidosis, or pre-coma. Patients with severe infections or traumatic systemic disorders should temporarily discontinue this medication, and it should also be stopped for a certain period before and after surgeries. Caution is needed when using this medication in patients with poor nutritional status, liver dysfunction, lung function impairment, or excessive alcohol intake. It is advisable for pregnant or potentially pregnant women and nursing mothers to avoid using this medication. This medication can induce hypoglycemic symptoms, so it should be taken with regular meals, and appropriate measures should be taken immediately if hypoglycemic symptoms occur. Additionally, this medication can cause gastrointestinal disturbances, but symptoms usually resolve over time. Regular testing of liver function, kidney function, and blood tests should be performed to monitor for abnormalities during treatment with this medication. It may interact with other medications, so if other drugs are being taken, the physician or pharmacist must be informed. In cases of overdose, severe hypoglycemia or lactic acidosis may occur, so immediate emergency treatment should be sought if symptoms develop. Caution should be exercised while driving or operating machinery, as hypoglycemic symptoms or blurred vision may occur. This medication should be stored out of reach of children, and transferring it to other containers should be avoided. Finally, while taking this medication, management of condition through regular meals, exercise, and periodic blood sugar and blood tests is essential.
Lactic acidosis, hypoglycemia, upper abdomen pain, diarrhea, nausea, vomiting, abdominal pain, loss of appetite, discomfort, metallic taste, pruritus, urticaria, maculopapular rash, allergic vasculitis, erythema multiforme, exfoliative dermatitis, photosensitivity, shock, leukopenia, thrombocytopenia, agranulocytosis, hemolytic anemia, aplastic anemia, pancytopenia, decreased vitamin B12 absorption, increased liver enzymes, hepatitis, hepatic porphyria, cutaneous porphyria, elevated serum urea and creatinine levels, acute hyponatremia, vision impairment, upper respiratory infection, headache, dizziness, bloating, thirst, increased appetite, dysuria, fatty liver, arthralgia, insomnia, cold sensation
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The medication is best stored at room temperature between 1 and 30 degrees Celsius. This helps maintain the efficacy and safety of the medication.
An oval, light orange, film-coated tablet that is convex on both sides with '2.5' engraved on one side.
60 tablets (20 tablets/PTP)×3, 120 tablets (20 tablets/PTP)×6
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Glibenclamide 2.5mg
Tablet · Prescription medication · Combination
(Ltd) Daewoong Pharmaceutical
CombinationMetformin Hydrochloride 500mg · Glibenclamide 2.5mg
Tablet · Prescription medication · Combination
Merck Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glibenclamide 5mg
Tablet · Prescription medication · Combination
Merck Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Glibenclamide 5mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.